ゲノミクス・パーソナライズドヘルスの世界市場レポート 2025年

ゲノミクス・パーソナライズドヘルス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR16.0％で336億米ドルに成長します。予測期間の成長は、ヘルスケア投資の増加、ゲノミクス技術の採用拡大、個別化医療の応用拡大、遺伝性疾患の有病率上昇、バイオバンクの拡大、慢性疾患の有病率上昇に起因すると考えられます。予測期間の主な動向には、ウェアラブル技術との統合、消費者直接遺伝子検査の成長、CRISPRと遺伝子編集の進歩、ゲノムとデジタルヘルスの統合、精密医療イニシアチブの拡大などが含まれます。

個別化医療への関心の高まりは、今後のゲノミクス・パーソナライズドヘルス市場の拡大を後押しする構えです。個別化医療は精密医療とも呼ばれ、個々の患者の特徴に合わせて医療介入をカスタマイズすることでヘルスケアに革命をもたらします。個別化医療に対する需要の急増は、予防医療への移行、治療成果の向上、患者の関与とエンパワーメントの強化、経済的メリット、慢性疾患や複雑な疾患の有病率の上昇に起因しています。ゲノミクス・パーソナライズドヘルスは、個人の遺伝子データを活用し、予防措置や診断から治療やモニタリングに至るまで、医療介入を調整することで、個別化医療を推進する上で極めて重要な役割を果たしています。例えば、米国を拠点とする非営利団体Personalized Medicine Coalitionが2024年2月に報告したように、FDA（食品医薬品局）は2023年に希少疾患に対する16の革新的な個別化治療を認可しました。したがって、個別化医療に対する需要の高まりがゲノミクス・パーソナライズドヘルス市場の成長を下支えしています。

ゲノミクス・パーソナライズドヘルス市場の主要企業は、臨床次世代シーケンス（NGS）データの三次解析用クラウドベースソフトウェアなどの革新的製品の開発に注力し、競合優位性を獲得しています。臨床NGSデータとは、シーケンシング技術によって得られる遺伝情報を指し、臨床現場においてDNAやRNAサンプルのハイスループットかつ詳細な解析を可能にします。例えば、DNAシーケンスとアレイベースの技術を専門とする米国のバイオテクノロジー企業であるイルミナは、2023年3月、臨床NGSデータの三次解析用に設計されたクラウドベースのソフトウェアであるConnected Insightsを発表しました。このプラットフォームは、特に腫瘍学アプリケーションにおける解釈と報告プロセスの最適化を目的とし、包括的なゲノムプロファイリングをサポートします。Connected Insightsは様々なサードパーティのナレッジベースを統合し、正確なデータ解析を容易にし、プレシジョン・ケア構想の効率を向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ゲノミクス・パーソナライズドヘルス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のゲノミクス・パーソナライズドヘルス市場：成長率分析
• 世界のゲノミクス・パーソナライズドヘルス市場の実績：規模と成長, 2019-2024
• 世界のゲノミクス・パーソナライズドヘルス市場の予測：規模と成長, 2024-2029, 2034F
• 世界ゲノミクス・パーソナライズドヘルス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のゲノミクス・パーソナライズドヘルス市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学検査
• 感染症検査
• 希少疾患検査
• 自己免疫疾患検査
• 産科検査
• その他のテストタイプ
• 世界のゲノミクス・パーソナライズドヘルス市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• NGSプラットフォーム
• RT-PCR
• マイクロアレイ
• 遺伝子分析装置
• 世界のゲノミクス・パーソナライズドヘルス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 学術調査機関
• 診断センター
• その他のエンドユーザー
• 世界のゲノミクス・パーソナライズドヘルス市場腫瘍学検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• がんゲノムプロファイリング
• 液体生検検査
• 腫瘍変異負荷試験
• 遺伝子バイオマーカー検査
• 世界のゲノミクス・パーソナライズドヘルス市場感染症検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCR検査
• 次世代シーケンシング（NGS）検査
• 微生物ゲノムプロファイリング
• 世界のゲノミクス・パーソナライズドヘルス市場希少疾患検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 希少疾患の遺伝子検査
• 遺伝性疾患の遺伝子検査
• 標的遺伝子パネル
• 世界のゲノミクス・パーソナライズドヘルス市場自己免疫疾患検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己免疫疾患の遺伝子検査
• 免疫システム遺伝子プロファイリング
• HLAタイピング検査
• 世界のゲノミクス・パーソナライズドヘルス市場産科検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的出生前検査（NIPT）
• 先天異常の遺伝子検査
• キャリアスクリーニング検査
• 世界のゲノミクス・パーソナライズドヘルス市場、その他のテストタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管遺伝子検査
• 神経疾患検査
• 代謝性疾患の遺伝子検査

第7章 地域別・国別分析

• 世界のゲノミクス・パーソナライズドヘルス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のゲノミクス・パーソナライズドヘルス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ゲノミクス・パーソナライズドヘルス市場：競合情勢
• ゲノミクス・パーソナライズドヘルス市場：企業プロファイル
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Exact Sciences Corporation
• QIAGEN N.V
• Natera Inc.
• Adaptive Biotechnologies Corporation
• Myriad Genetics Inc.
• NanoString Technologies Inc.
• Pacific Biosciences of California Inc.
• Personalis Inc.
• DNA Genotek Inc.
• Twist Bioscience Corporation
• GRAIL Inc.
• Eastern Biotech and Life Sciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ゲノミクス・パーソナライズドヘルス市場2029：新たな機会を提供する国
• ゲノミクス・パーソナライズドヘルス市場2029：新たな機会を提供するセグメント
• ゲノミクス・パーソナライズドヘルス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genomics personalized health involves customizing medical care and treatments based on an individual's genomic data, taking into account their specific genetic characteristics, lifestyle choices, and environmental factors. This method utilizes progress in genomics, bioinformatics, and personalized medicine to offer more accurate and efficient healthcare solutions personalized to each person's genetic inclinations, susceptibilities, and responses to treatment.

The primary test types of genomics personalized health comprise oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves employing genetic testing methods to identify cancer and ascertain its unique attributes, utilizing technologies such as NGS platforms, RT-PCR, microarray, and genetic analyzers. These tests cater to end users such as academic research institutes, diagnostic centers, and others.

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides genomics personalized health market statistics, including the genomics personalized health industry global market size, regional shares, competitors with genomics personalized health market share, detailed genomics personalized health market segments, market trends, and opportunities, and any further data you may need to thrive in the genomics personalized health industry. These genomics personalized health market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomics personalized health market size has grown rapidly in recent years. It will grow from $15.97 billion in 2024 to $18.58 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to advancements in genomics research, government funding, and support, a rise in chronic diseases, technological innovations, pharmaceutical industry investment, collaborations, and partnerships.

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $33.6 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to increasing healthcare investments, growing adoption of genomics technologies, expanding applications of personalized medicine, rising prevalence of genetic disorders, expansion of biobanks, and increasing prevalence of chronic diseases. Major trends in the forecast period include integration with wearable technology, growth of direct-to-consumer genetic testing, advancements in CRISPR and gene editing, integration of genomics with digital health, and expansion of precision medicine initiatives.

The increasing interest in personalized medicine is poised to drive the expansion of the genomics personalized health market in the future. Personalized medicine, also referred to as precision medicine, revolutionizes healthcare by customizing medical interventions to suit the unique characteristics of individual patients. The surge in demand for personalized medicine stems from a transition towards preventive healthcare, enhanced treatment outcomes, heightened patient involvement and empowerment, economic advantages, and the escalating prevalence of chronic and intricate ailments. Genomics personalized health plays a pivotal role in advancing personalized medicine by harnessing individual genetic data to tailor medical interventions, spanning from preventive measures and diagnosis to treatment and monitoring. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, the Food and Drug Administration (FDA) sanctioned 16 innovative personalized therapies for rare diseases in 2023, in contrast to six in 2022. Hence, the escalating demand for personalized medicine underpins the growth of the genomics personalized health market.

Leading companies in the genomics personalized health market are focusing on developing innovative products, such as cloud-based software for tertiary analysis of clinical next-generation sequencing (NGS) data, to gain a competitive edge. Clinical NGS data refers to genetic information obtained through sequencing technologies, enabling high-throughput, detailed analysis of DNA or RNA samples in clinical settings. For example, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, launched Connected Insights, a cloud-based software designed for the tertiary analysis of clinical NGS data. This platform aims to optimize the interpretation and reporting processes, particularly for oncology applications, and supports comprehensive genomic profiling. Connected Insights integrates various third-party knowledge bases, facilitating accurate data analysis and improving the efficiency of precision care initiatives.

In January 2022, Exact Sciences Corp., a US-based biotechnology research company, completed the acquisition of PreventionGenetics for an undisclosed sum. This strategic move was intended to enhance Exact Sciences' capabilities in cancer screening and diagnostics, with a specific focus on hereditary cancer testing, in order to further the cause of personalized healthcare and promote early cancer detection. PreventionGenetics, also based in the US, is a biotechnology research company specializing in genomics personalized health.

Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.

North America was the largest region in the personalized health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomics personalized health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The genomics personalized health market consists of revenues earned by entities by providing services such as genomic sequencing, bioinformatics analysis, genetic testing, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of DNA sequencing kits, genomic data management solutions, pharmacogenomics tests, personalized wellness and nutrition products, and companion diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Personalized Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics personalized health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics personalized health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics personalized health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Orphan Disease Testing; Autoimmune Disease Testing; Obstetrics Testing; Other Test Type
• 2) By Technology: NGS platforms; RT-PCR; Microarray; Genetic Analyzers
• 3) By End User: Academic Research Institutes; Diagnostic Centers; Other End Users
• Subsegments:
• 1) Oncology Testing: Cancer Genomic Profiling; Liquid Biopsy Testing; Tumor Mutational Burden Testing; Genetic Biomarker Testing
• 2) Infectious Disease Testing: PCR-Based Tests; Next-Generation Sequencing (NGS) Tests; Microbial Genomic Profiling
• 3) Orphan Disease Testing: Genetic Screening For Rare Diseases; Genetic Testing For Inherited Disorders; Targeted Gene Panels
• 4) Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions; Immune System Gene Profiling; HLA Typing Tests
• 5) Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT); Genetic Screening For Birth Defects; Carrier Screening Tests
• 6) Other Test Type: Cardiovascular Genetic Testing; Neurological Disease Testing; Metabolic Disease Genetic Testing
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Quest Diagnostics; Agilent Technologies Inc.; Lonza Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomics Personalized Health Market Characteristics

3. Genomics Personalized Health Market Trends And Strategies

4. Genomics Personalized Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genomics Personalized Health Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomics Personalized Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomics Personalized Health Market Growth Rate Analysis
• 5.4. Global Genomics Personalized Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomics Personalized Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomics Personalized Health Total Addressable Market (TAM)

6. Genomics Personalized Health Market Segmentation

• 6.1. Global Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Testing
• Infectious Disease Testing
• Orphan Disease Testing
• Autoimmune Disease Testing
• Obstetrics Testing
• Other Test Type
• 6.2. Global Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NGS platforms
• RT-PCR
• Microarray
• Genetic Analyzers
• 6.3. Global Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Research Institutes
• Diagnostic Centers
• Other End User
• 6.4. Global Genomics Personalized Health Market, Sub-Segmentation Of Oncology Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Genomic Profiling
• Liquid Biopsy Testing
• Tumor Mutational Burden Testing
• Genetic Biomarker Testing
• 6.5. Global Genomics Personalized Health Market, Sub-Segmentation Of Infectious Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR-Based Tests
• Next-Generation Sequencing (NGS) Tests
• Microbial Genomic Profiling
• 6.6. Global Genomics Personalized Health Market, Sub-Segmentation Of Orphan Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Screening For Rare Diseases
• Genetic Testing For Inherited Disorders
• Targeted Gene Panels
• 6.7. Global Genomics Personalized Health Market, Sub-Segmentation Of Autoimmune Disease Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Screening For Autoimmune Conditions
• Immune System Gene Profiling
• HLA Typing Tests
• 6.8. Global Genomics Personalized Health Market, Sub-Segmentation Of Obstetrics Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Genetic Screening For Birth Defects
• Carrier Screening Tests
• 6.9. Global Genomics Personalized Health Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Genetic Testing
• Neurological Disease Testing
• Metabolic Disease Genetic Testing

7. Genomics Personalized Health Market Regional And Country Analysis

• 7.1. Global Genomics Personalized Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomics Personalized Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics Personalized Health Market

• 8.1. Asia-Pacific Genomics Personalized Health Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics Personalized Health Market

• 9.1. China Genomics Personalized Health Market Overview
• 9.2. China Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics Personalized Health Market

• 10.1. India Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics Personalized Health Market

• 11.1. Japan Genomics Personalized Health Market Overview
• 11.2. Japan Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics Personalized Health Market

• 12.1. Australia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics Personalized Health Market

• 13.1. Indonesia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics Personalized Health Market

• 14.1. South Korea Genomics Personalized Health Market Overview
• 14.2. South Korea Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics Personalized Health Market

• 15.1. Western Europe Genomics Personalized Health Market Overview
• 15.2. Western Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics Personalized Health Market

• 16.1. UK Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics Personalized Health Market

• 17.1. Germany Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics Personalized Health Market

• 18.1. France Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics Personalized Health Market

• 19.1. Italy Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics Personalized Health Market

• 20.1. Spain Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics Personalized Health Market

• 21.1. Eastern Europe Genomics Personalized Health Market Overview
• 21.2. Eastern Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics Personalized Health Market

• 22.1. Russia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics Personalized Health Market

• 23.1. North America Genomics Personalized Health Market Overview
• 23.2. North America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics Personalized Health Market

• 24.1. USA Genomics Personalized Health Market Overview
• 24.2. USA Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics Personalized Health Market

• 25.1. Canada Genomics Personalized Health Market Overview
• 25.2. Canada Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics Personalized Health Market

• 26.1. South America Genomics Personalized Health Market Overview
• 26.2. South America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics Personalized Health Market

• 27.1. Brazil Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics Personalized Health Market

• 28.1. Middle East Genomics Personalized Health Market Overview
• 28.2. Middle East Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics Personalized Health Market

• 29.1. Africa Genomics Personalized Health Market Overview
• 29.2. Africa Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics Personalized Health Market Competitive Landscape And Company Profiles

• 30.1. Genomics Personalized Health Market Competitive Landscape
• 30.2. Genomics Personalized Health Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group Overview, Products and Services, Strategy and Financial Analysis

31. Genomics Personalized Health Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Illumina Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Exact Sciences Corporation
• 31.5. QIAGEN N.V
• 31.6. Natera Inc.
• 31.7. Adaptive Biotechnologies Corporation
• 31.8. Myriad Genetics Inc.
• 31.9. NanoString Technologies Inc.
• 31.10. Pacific Biosciences of California Inc.
• 31.11. Personalis Inc.
• 31.12. DNA Genotek Inc.
• 31.13. Twist Bioscience Corporation
• 31.14. GRAIL Inc.
• 31.15. Eastern Biotech and Life Sciences

32. Global Genomics Personalized Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics Personalized Health Market

34. Recent Developments In The Genomics Personalized Health Market

35. Genomics Personalized Health Market High Potential Countries, Segments and Strategies

• 35.1 Genomics Personalized Health Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomics Personalized Health Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomics Personalized Health Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer